In this webinar we will cover:

  • Glycosylation and glycan diversity
  • Monosaccharides and oligosaccharides structure
    • Why study glycans?
      • Which glycans are analyzed? N or O linked
      • Importance of protein glycosylation
    • What role do glycans play in biotherapeutics?
      • Efficacy
      • Clearance
      • Toxicity
      • Stability of the structure
  • Key critical quality attributes of mAb-based biotherapeutics
  • Regulatory guidance
  • Glycan analysis challenges
  • Background and history of glycan analysis
  • Key areas of product development
Shaheer Khan, PhD

About the presenter

Shaheer Khan, PhD
Shaheer Khan is a senior staff scientist at Thermo Fisher Scientific and has worked in biotechnology companies for over 20 years. He is the author or coauthor of over 25 journal articles and book chapters, and the coeditor of 1 book volume. Shaheer holds over 25 issued US patents.

Complete this form to view the on-demand webinar.

(*Indicates a mandatory field)